SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : The biotechnology mini portfolio -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (4)7/20/2006 1:38:12 AM
From: Mike McFarland  Read Replies (1) | Respond to of 93
 
MiniB cost, marketcap, value
MEDX MEDAREX INC $10 1.17B $9,580
MYGN MYRIAD GENETICS $23 931.59M $10,152
ARNA ARENA PHARMACEUTIC $10 471.56M $9,980
CRXL CRUCELL NV ADS $20 1.12B $9,440
MAXY MAXYGEN INC $7.50 269.77M $9,997
Total (USD): $49,149

note to self, selected simple display, deleted
all but cost, MC, value for now

Just experimenting to see what quick paste from Yahoo looks
best. I will eventually do up a spreadsheet or something
that looks better. Don't know why the value changed, but
the starting ~$49k will just let us forget about any cost
from commissions for, say, five years. Front end load of 2%
ha ha.



To: Mike McFarland who wrote (4)7/20/2006 9:23:27 AM
From: tom pope  Respond to of 93
 
Yes it was - but not great at all when I brought up the details - first buy was at 63.69 in May 2000 (what a horrible time to buy any biotech!), my last sale was in November for 41. Sold some along the way in the 50's. That was it for me, it seems.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News